Correlation Between Biomarin Pharmaceutical and Nuvalent
Can any of the company-specific risk be diversified away by investing in both Biomarin Pharmaceutical and Nuvalent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biomarin Pharmaceutical and Nuvalent into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biomarin Pharmaceutical and Nuvalent, you can compare the effects of market volatilities on Biomarin Pharmaceutical and Nuvalent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biomarin Pharmaceutical with a short position of Nuvalent. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biomarin Pharmaceutical and Nuvalent.
Diversification Opportunities for Biomarin Pharmaceutical and Nuvalent
0.16 | Correlation Coefficient |
Average diversification
The 3 months correlation between Biomarin and Nuvalent is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Biomarin Pharmaceutical and Nuvalent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvalent and Biomarin Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biomarin Pharmaceutical are associated (or correlated) with Nuvalent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvalent has no effect on the direction of Biomarin Pharmaceutical i.e., Biomarin Pharmaceutical and Nuvalent go up and down completely randomly.
Pair Corralation between Biomarin Pharmaceutical and Nuvalent
Given the investment horizon of 90 days Biomarin Pharmaceutical is expected to under-perform the Nuvalent. But the stock apears to be less risky and, when comparing its historical volatility, Biomarin Pharmaceutical is 1.88 times less risky than Nuvalent. The stock trades about -0.04 of its potential returns per unit of risk. The Nuvalent is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 3,136 in Nuvalent on November 9, 2024 and sell it today you would earn a total of 5,534 from holding Nuvalent or generate 176.47% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Biomarin Pharmaceutical vs. Nuvalent
Performance |
| Timeline |
| Biomarin Pharmaceutical |
| Nuvalent |
Biomarin Pharmaceutical and Nuvalent Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biomarin Pharmaceutical and Nuvalent
The main advantage of trading using opposite Biomarin Pharmaceutical and Nuvalent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biomarin Pharmaceutical position performs unexpectedly, Nuvalent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvalent will offset losses from the drop in Nuvalent's long position.| Biomarin Pharmaceutical vs. Alnylam Pharmaceuticals | Biomarin Pharmaceutical vs. Exelixis | Biomarin Pharmaceutical vs. Halozyme Therapeutics | Biomarin Pharmaceutical vs. Arrowhead Pharmaceuticals |
| Nuvalent vs. Arcellx | Nuvalent vs. Vaxcyte | Nuvalent vs. Viridian Therapeutics | Nuvalent vs. Ventyx Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |